Crossmark

Nation-wide survey of screening practices to detect carriers of multi-drug resistant organisms upon admission to Swiss healthcare institutions

Crossref DOI link: https://doi.org/10.1186/s13756-019-0479-5

Published Online: 2019-02-13

Published Print: 2019-12

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Martischang, Romain http://orcid.org/0000-0001-5071-0893
Buetti, Niccolo

Balmelli, Carlo

Saam, Mirko

Widmer, Andreas

Harbarth, Stephan
Funding

Funding for this research was provided by:

Swiss Federal Office of Public Health

Swiss National Science Foundation (407240_177454)
License Information

Text and Data Mining valid from 2019-02-13
More Information

Article History

Received: 8 November 2018

Accepted: 25 January 2019

First Online: 13 February 2019

Ethics approval and consent to participate

: Not applicable.

: Not applicable.

: S.H. has participated in scientific advisory boards of DNA Electronics, Sandoz, GSK and Bayer; and has received financial support for research activities from the European Commission. The other authors declare no conflicts of interest.

: Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.